News
Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...
12h
GlobalData on MSNThe GLP-1 drug shortage is over. What’s next for the compounders?Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...
20h
HealthDay on MSNAdverse Events From Semaglutide Seen in the ED Usually GI-RelatedThe rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits ...
A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...
The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...
A Kentucky physician is facing up to three years in prison after distributing non-FDA approved semaglutide drugs, prosecutors ...
Girls Next Door alum Kendra Wilkinson shared that she recently tried using a weight loss drug but quickly changed her mind, citing “too many horror stories around me.” ...
Presentation Title: Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass and Physical Function in Older Patients Receiving Semaglutide for Weight Loss Date: April 30, 2025 Start time: 12:30 ...
9h
American Woman on MSNSmart and Sustainable Weight Loss Solutions for the Demands of Modern LifeWeight struggles can feel daunting when life moves fast. Most people are busy with their family, jobs, and other oblig ...
Ohio Attorney General Dave Yost issued a warning to several Ohio medical spas over their alleged claims regarding weight-loss drugs.
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ ...
9h
Verywell Health on MSN4 Foods to Avoid and 3 You Should Eat While Taking OzempicCertain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results